Search

Search Constraints

You searched for: Author/Creator Rea, Daniel W.

Search Results

1. HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12, 129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2. (July 2017)

2. OPTIMA (Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis): A prospective trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions. Issue 5 (May 2016)

3. Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial. (January 2020)